By not excluding other pathogenic variants associated with hereditary cancer risk, the actual assessment of the risk conferred solely by the APC I1307K variant may have been overestimated by the presence of other pathogenic variants that confer a substantially increased risk common in AJ (e.g., BRCA1 and BRCA2). This evidence concerns the gene BRCA1 and hereditary cancer.